Vella Bioscience has a total of 27 patents globally, out of which 1 has been granted. Of these 27 patents, more than 88% patents are active. United States of America is where Vella Bioscience has filed the maximum number of patents, followed by New Zealand and Australia. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Vella Bioscience.
Vella Bioscience was founded in the year 2020. The Company operates as a clinical-stage biotechnology company. The Company develops and commercializes therapeutics and medicines for the treatment of patients with autoimmune and severe inflammatory diseases.
Do read about some of the most popular patents of Vella Bioscience which have been covered by us in this article and also you can find Vella Bioscience patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Vella Bioscience patent portfolio.
How many patents does the founder and the CEO of Vella Bioscience have?
The founder Carolyn Wheeler has 0 patent and Harin Padma-Nathan has 5 patents and CEO Nial Chase DeMena has 2 patents.
How many patents does Vella Bioscience have?
Vella Bioscience has a total of 27 patents globally. These patents belong to 4 unique patent families. Out of 27 patents, 24 patents are active.
How Many Patents did Vella Bioscience File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Vella Bioscience Applications Filed | Vella Bioscience Patents Granted |
| 2023 | 3 | 1 |
| 2022 | 4 | – |
| 2021 | 9 | – |
| 2020 | 11 | – |
How many Vella Bioscience patents are Alive/Dead?
How Many Patents did Vella Bioscience File in Different Countries?
Countries in which Vella Bioscience Filed Patents
| Country | Patents |
| United States Of America | 5 |
| New Zealand | 2 |
| Australia | 2 |
| Europe | 2 |
| Canada | 2 |
| Singapore | 2 |
| Israel | 2 |
| South Africa | 2 |
| Korea (South) | 2 |
| Mexico | 2 |
Where are Research Centres of Vella Bioscience Patents Located?
The Research Centre for all the Vella Bioscience patents is the United States of America.
What Percentage of Vella Bioscience US Patent Applications were Granted?
Vella Bioscience (Excluding its subsidiaries) has filed 3 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 0 have been granted leading to a grant rate of 0.0%.
Below are the key stats of Vella Bioscience patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Vella Bioscience?
| Law Firm | Total Applications | Success Rate |
| Ip Supra Pllc | 3 | 0% |
List of Vella Bioscience Patents
| Vella Bioscience Patents | Title |
| US11717495B2 | Use Of Cannabinoids In Treating Anti-Depressant-Induced Female Sexual Dysfunction |
| US20230338304A1 | Use Of Cannabinoids In Treating Anti-Depressant-Induced Female Sexual Dysfunction |
| US20230321017A1 | Acidic Cannabinoids And Uses Thereof For Enhancing Female Sexual Function Or Treating Female Sexual Disorders |
| US20220401381A1 | Peripherally Acting Cannabidiol (Cbd)-Containing Compounds And Uses Thereof For Enhancing Female Sexual Function Or Treating Female Sexual Disorders |
| US20220395547A1 | Liposomal Formulations For Delivery Of Cannabinoids And Methods Of Making Thereof |
| EP4121039A4 | Use Of Cannabidiol In Treating Anti-Depressant-Induced Female Sexual Dysfunction |
| EP4054335A4 | Peripherally Acting Cannabidiol(Cbd)-Containing Compositions And Uses Thereof For Enhancing Female Sexual Function Or Treating Female Sexual Disorders |
| WO2023183154A2 | Acidic Cannabinoids And Uses Thereof For Enhancing Female Sexual Function Or Treating Female Sexual Disorders |
| AU2021238290A1 | Use Of Cannabidiol In Treating Anti-Depressant-Induced Female Sexual Dysfunction |
| AU2020377914A1 | Peripherally Acting Cannabidiol(Cbd)-Containing Compositions And Uses Thereof For Enhancing Female Sexual Function Or Treating Female Sexual Disorders |
| CA3173969A1 | Use Of Cannabidiol In Treating Anti-Depressant-Induced Female Sexual Dysfunction |
| CA3160634A1 | Peripherally Acting Cannabidiol(Cbd)-Containing Compositions And Uses Thereof For Enhancing Female Sexual Function Or Treating Female Sexual Disorders |
| IL296300A | Use Of Cannabidiol In Treating Anti-Depressant-Induced Female Sexual Dysfunction |
| IL292775A | Peripherally Acting Cannabidiol(Cbd)-Containing Compositions And Uses Thereof For Enhancing Female Sexual Function Or Treating Female Sexual Disorders |
| SG11202253006CA | Use Of Cannabidiol In Treating Anti-Depressant-Induced Female Sexual Dysfunction |
| SG11202204772YA | Peripherally Acting Cannabidiol(Cbd)-Containing Compositions And Uses Thereof For Enhancing Female Sexual Function Or Treating Female Sexual Disorders |
| KR1020220154129A | Use Of Cannabidiol In The Treatment Of Antidepressant-Induced Female Sexual Dysfunction |
| MX2022011019A | Use Of Cannabidiol In The Treatment Of Female Sexual Dysfunction Induced By Antidepressants |
| ZA202211315A | Use Of Cannabidiol In Treating Anti-Depressant-Induced Female Sexual Dysfunction |
| KR1020220099991A | Peripherally Acting Cannabidiol (Cbd) Containing Composition For Improving Female Sexual Function Or Treating Female Dystonia And Use Thereof |
| ZA202206053A | Peripherally Acting Cannabidiol(Cbd)-Containing Compositions And Uses Thereof For Enhancing Female Sexual Function Or Treating Female Sexual Disorders |
| MX2022005450A | Peripherally Acting Cannabidiol(Cbd)-Containing Compositions And Uses Thereof For Enhancing Female Sexual Function Or Treating Female Sexual Disorders. |
| NZ792511A | Use Of Cannabidiol In Treating Anti-Depressant-Induced Female Sexual Dysfunction |
| NZ788234A | Peripherally Acting Cannabidiol(Cbd)-Containing Compositions And Uses Thereof For Enhancing Female Sexual Function Or Treating Female Sexual Disorders |
| WO2021188388A1 | Use Of Cannabidiol In Treating Anti-Depressant-Induced Female Sexual Dysfunction |
| WO2021091905A4 | Liposomal Formulations For Delivery Of Cannabinoids And Methods Of Making Thereof |
| WO2021091908A1 | Peripherally Acting Cannabidiol(Cbd)-Containing Compositions And Uses Thereof For Enhancing Female Sexual Function Or Treating Female Sexual Disorders |
What are Vella Bioscience key innovation segments?
What Technologies are Covered by Vella Bioscience?
The chart below distributes patents filed by Vella Bioscience